HomeFileCoronary disease

Coronary disease

EuroPCR 2022 | The IMPROVED-CTO Trial

PCI success rate in chronic total occlusion (CTO), according to some registries, is below 80%. These failed...

EuroPCR 2022 | GLOBAL SYMPLICITY Registry

The GLOBAL SYMPLICITY Registry is the largest study, with the longest followup, of real-world patients (real world...

Transfemoral vs Transradial Approach in the Percutaneous Treatment of CTO

Percutaneous treatment of chronic total occlusion (CTO) has traditionally been via the transfemoral approach (TFA). The use...

Improved Ventricular Function Post Revascularization: Fewer Events across Subgroups?

According to the STITCH and STITCHES trials, in patients with coronary artery disease and deteriorated left ventricular...

Should We Worry about Non-Ischemic Lesions?

In the last decade, the interest in atheroma plaque morphology and its role in clinical events has...

Coronary Flow Reserve in Patients with Intermediate FFR: Should We Use This Tool to Define When to Perform Coronary Angioplasty?

Current guidelines recommend using fractional flow reserve (FFR) to guide coronary angioplasty. However, intermediate FFR values (0.75-0.80)...

Should We Start Using OCT in Myocardial Infarction with Non-Obstructive Lesions?

In ST elevation MI, the common assessment methodology continues to the angiography; however, we all know it...

Can the Use of Intra Arterial Vasodilators Prevent Radial Artery Occlusion?

The incidence of post procedure radial occlusion (RAO) ranges from 1% to 12 % according to some...